Human myeloperoxidase activity is inhibited in vitro by quercetin. Comparison with three related compounds

Experientia. 1988 May 15;44(5):450-3. doi: 10.1007/BF01940544.

Abstract

Quercetin is an effective inhibitor of human myeloperoxidase (MPO) activity, both with purified enzyme (IC50 = 3.5 microM) and in a system using stimulated human neutrophils. Quercetin is significantly more potent than three other related compounds (rutin, rutin sulfate and troxerutin) and than methimazole, a previously-known myeloperoxidase inhibitor. The inhibitory activity of quercetin is of the competitive type. Moreover, quercetin is directly able to scavenge hypochlorous acid (HOCl), a chlorinated species generated by the MPO/H2O2/Cl- system.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Chemical Phenomena
  • Chemistry
  • Flavonoids / pharmacology*
  • Humans
  • Hydroxyethylrutoside / analogs & derivatives
  • Hydroxyethylrutoside / pharmacology
  • Hypochlorous Acid
  • Methimazole / pharmacology
  • Neutrophils / enzymology
  • Peroxidase / antagonists & inhibitors*
  • Quercetin / pharmacology*
  • Rutin / analogs & derivatives
  • Rutin / pharmacology
  • Spectrophotometry

Substances

  • Flavonoids
  • Hydroxyethylrutoside
  • rutin sulfate
  • Methimazole
  • Rutin
  • Hypochlorous Acid
  • troxerutin
  • Quercetin
  • Peroxidase